Arrowhead Research reported $-31868000 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Anika Therapeutics ANIK:US $ -2262000 1.28M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
Arrowhead Research ARWR:US $ -31868000 3.64M
Bluebird Bio BLUE:US $ -240791000 9.95M
Cerulean Pharma CERU:US $ -9162930 1.47M
Dicerna Pharmaceuticals DRNA:US $ -40244000 11.14M
Heron Therapeutics HRTX:US $ -60469000 8.36M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
Ligand Pharmaceuticals LGND:US $ 45.76M 41.04M
Merk MRK:US $ 3930M 332M
Mirati Therapeutics MRTX:US $ -164186000 31.76M
Moderna Inc MRNA:US 3.06B 1.8B
Nektar Therapeutics NKTR:US $ -110205000 813K
Novartis NOVN:VX 3.4B 415M
Opko Health OPK:US $ 5.57M 32.87M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Spectrum Pharmaceuticals SPPI:US $ -44071000 10.38M
Tg Therapeutics TGTX:US $ -77492000 11.71M
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
Xencor XNCR:US $ 9.09M 24.76M
YTE INCY:US $ 155.31M 40.5M